All-trans-Retinoic Acid and 13-cis-Retinoic Acid: Pharmacokinetics and Biological Activity in Different Cell Culture Models of Human Keratinocytes

 

 Buy Article Permissions and Reprints

Abstract

Despite its known biological effect on epithelial cells, 13-cis-retinoic acid shows low binding affinity to either cellular retinoic acid-binding proteins or nuclear retinoid receptors compared to its isomer all-trans-retinoic acid. We have postulated a prodrug-drug relation with 13-cis-retinoic acid which isomerizes to all-trans-retinoic acid. On the other hand, the biological effects of these two compounds can differ in the widely used cell culture models of HaCaT and normal primary keratinocytes. In this study, we seeded HaCaT and normal keratinocytes at high densities leading to early confluence in order to imitate high keratinocyte proliferation, such as in acne and psoriasis, while to model decreased keratinocyte proliferation, as in aged and steroid-damaged skin, cells were seeded at a low density. High performance liquid chromatography was administered to examine retinoid uptake and metabolism in monolayer HaCaT and normal keratinocyte cultures and the 4-methylumbelliferyl heptanoate assay to estimate cell growth at different cell densities. Major qualitative and quantitative differences were detected in the two cell types regarding intracellular 13-cis-retinoic acid isomerization to all-trans-retinoic acid. On the other hand, the two retinoic acid isomers showed similar effects on cell growth of both cell types tested with increasing proliferation at low cell densities, but being rather inactive at high ones in normal keratinocytes and exhibiting an antiproliferative effect in HaCaT keratinocytes. The missing effect of retinoids on cell proliferation in high seeding densities of normal keratinocytes may indicate that the normalizing activity of retinoids on hyperkeratotic diseases, such as acne or psoriasis, is likely to be carried out by modulation of cell differentiation than cell growth. On the other hand, induced keratinocyte proliferation in low seeding densities may provide an explanation for the acanthosis induced by topical retinoids in aged and steroid-damaged skin.

References

• 1 Orfanos CE, Zouboulis CC, Almond-Roesler B, Geilen CC. Current use and future potential role of retinoids in dermatology.  Drugs. 1997;  53 358-388
  PubMedGoogle Scholar
• 2 Craven NM, Griffiths CEM. Topical retinoids and cutaneous biology.  Clin and Exper Dermatol. 1996;  21 1-10
  CrossrefPubMedGoogle Scholar
• 3 Fisher GJ, Voorhees JJ. Molecular mechanisms of retinoid actions in skin.  FASEB J. 1996;  10 1002-1013
  PubMedGoogle Scholar
• 4 Zouboulis CC, Korge B, Akamatsu H, Xia L, Schiller S, Gollnick H, Orfanos CE. Effects of 13-cis-retinoic acid, all-trans-retinoic acid and acitretin on the proliferation, lipid synthesis and keratin expression of cultured human sebocytes in vitro.  J Invest Dermatol. 1991;  96 792-797
  CrossrefPubMedGoogle Scholar
• 5 Tsukada M, Schröder M, Roos TC, Chandraratna RA, Reichert U, Merk HF, Orfanos CE, Zouboulis CC. 13-cis-retinoic acid exerts its specific activity on human sebocytes through selective intracellular isomerization to all-trans-retinoic acid and binding to retinoic acid receptors.  J Invest Dermatol. 2000;  115 321-327
  CrossrefPubMedGoogle Scholar
• 6 Boukamp P, Petrussevka RT, Breitkreuz D, Hornung J, Markham A, Fusening NE. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line.  J Cell Biol. 1988;  106 761-771
  CrossrefPubMedGoogle Scholar
• 7 Törmä H, Rollmann O, Vahlquist A. The vitamin A metabolism and expression of retinoid-binding proteins differ in HaCaT cells and normal human keratinocytes.  Arch Dermatol Res. 1999;  291 339-345
  CrossrefPubMedGoogle Scholar
• 8 Collins MD, Eckhoff C, Chahoud I, Bochert G, Nau H. 4-methylpyrazole partially ameliorated the teratogenicity of retinol and reduced the metabolic formation of all-trans-retinoic acid in the mouse.  Arch Toxicol. 1992;  66 652-659
  PubMedGoogle Scholar
• 9 Tzimas G, Bürgin H, Collins MD, Hummler H, Nau H. The high sensitivity of the rabbit to the teratogenic effects of 13-cis-retinoic acid (isotretinoin) is a consequence of prolonged exposure of the embryo to 13-cis-retinoic acid and 13-cis-4-oxo-retinoic acid, and not of isomerization to all-trans-retinoic acid.  Arch Toxicol. 1994;  68 119-128
  PubMedGoogle Scholar
• 10 Akamatsu H, Zouboulis CC, Orfanos CE. Spironolactone directly inhibits proliferation of cultured human facial sebocytes and acts antagonistically to testosterone and 5-alpha-dihydrotestosterone in vitro.  J Invest Dermatol. 1993;  100 660-662
  CrossrefPubMedGoogle Scholar
• 11 Tsukada M, Schröder M, Seltmann H, Orfanos CE, Zouboulis CC. High albumin levels restrict the kinetics of 13-cis retinoic acid uptake and intracellular isomerization to all-trans retinoic acid and inhibit its anti-proliferative effect on SZ95 sebocytes.  J Invest Dermatol. 2002;  119 182-185
  CrossrefPubMedGoogle Scholar
• 12 Hodam JR, Creek KE. Uptake and metabolism of (łH)retinoic acid delivered to human foreskin keratinocytes either bound to serum albumin or added directly to the culture medium.  Bioch Biophys. 1996;  1311 102-110
  PubMedGoogle Scholar
• 13 Wróbel A, Seltmann H, Fimmel S, Müller-Decker K, Tsukada M, Bogdanoff B, Mandt N, Blume-Peytavi U, Orfanos CE, Zouboulis CC. Differentiation and apoptosis in human immortalized sebocytes.  J Invest Dermatol. 2003;  120 175-181
  CrossrefPubMedGoogle Scholar
• 14 Napoli JL. Retinoic acid biosynthesis and metabolism.  FASEB J. 1996;  10 993-1001
  CrossrefPubMedGoogle Scholar
• 15 Zouboulis CC, Korge BP, Mischke D, Orfanos CE. Altered proliferation, synthetic activity, and differentiation of cultured human sebocytes in the absence of vitamin A and their modulation by synthetic retinoids.  J Invest Dermatol. 1993;  101 628-633
  CrossrefPubMedGoogle Scholar

Correspondence

C. C. Zouboulis

Departments of Dermatology and Immunology

Dessau Medical Center

Auenweg 38

06847 Dessau

Germany

Phone: +49/340/501 40 00

Fax: +49/340/501 40 25

Email: christos.zouboulis@klinikum-dessau.de